A new glucuronlylated prodrug of nornitrogen mustard, incorporating the sam
e spacer group as the doxorubicin prodrug HMR 1826, has been prepared. Upon
exposure to E. coli beta-glucuronidase, fast hydrolysis occurs but a lower
cytotoxicity against LoVo cancer cells is observed compared to the nornitr
ogen mustard alone. This is explained by cyclization of the intermediate ca
rbamic acid to the inactive chloroethyl oxazolidinone. (C) 2000 Elsevier Sc
ience Ltd. All rights reserved.